Page 60 - Read Online
P. 60

Page 6 of 50                       Siddiqui et al. Chem Synth 2023;3:25  https://dx.doi.org/10.20517/cs.2023.02













































                                  Figure 5. Biotransformation of (+)-menthol (21) with Macrophomina phaseolina.

               methyloxepin-1-one (32) (2%) [Proposed Supplementary Figure 1], along with two known metabolites, 3-
               hydroxy-5-isopropyl-2-methylcyclohexa-2,5-diene-1,4-dione (33) (8%), and 5-isopropyl-2-methylbenzene-
               1,4-diol (34) (28%)  [Figure 6] [Proposed Supplementary Figure 2].
                               [26]

               BIOTRANSFORMATION OF SESQUITERPENES
               Biotransformation of (+)-isolongifolen-4-one (35)
               Five new oxidative derivatives, 12-hydroxyisolongifolen-4-one (36), 13-hydroxyisolongi-folen-4-one (37),
               11-hydroxyisolongifolen-4-one (38), 10-hydroxyisolongifolen-4-one (39), and 9-hydroxyisolongifolen-4-
                                                                                                        [27]
               one (40) were synthesized through the microbial transformation of (+)-isolongifolen-4-one (35)
               [Figure 7]. Compound 35 is used in the perfumery industry. Derivatives 37 (IC  = 9.64 ± 0.0008 μM) and 40
                                                                                  50
               (IC  = 6.68 ± 0.0096 μM) were identified as potent inhibitors of tyrosinase, an important enzyme for
                  50
               melanin biosynthesis, as compared to substrate 35 (IC  = 51.91 ± 0.0245 μM). Metabolite 36 showed
                                                                50
               moderate inhibitory activity (IC  = 101.01 ± 0.1978 μM).
                                          50
               Biotransformation of (-)-isolongifolol (41)
               Biotransformation of (-)-isolongifolol (41) with Fusarium lini resulted in three new polar oxygenated
               derivatives,  10-oxoisolongifolol  (42)  (1.2%),  10α-hydroxyisolongifolol  (43)  (16%),  and  9α-
               hydroxyisolongifolol (44) (22%). The presence of an α-OH at C-10 in the metabolite 42 increased its
               inhibitory potential against butyrylcholinesterase, an enzyme whose inhibition reduces memory deficiency
               in Alzheimer’s patients, with the IC  value of 13.6 μM, while the presence of an α-OH at C-11 in the
                                               50
   55   56   57   58   59   60   61   62   63   64   65